S H Kelkar & Company Ltd Q2 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Published 28 May 2026 | Chemicals & Petrochemicals | Market Cap: ₹2.4K Cr

The company expects a revenue CAGR of approximately 15% over the next 3 to 4 years. Revenue Growth:** Company targets a CAGR of around 15% over the next 3-4 years.

From S H Kelkar & Company Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Price

157

Market Cap

₹2.4K Cr

P/E Ratio

50.0

How does S H Kelkar & Company Ltd rank in Chemicals & Petrochemicals?

Compare S H Kelkar & Company Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

S H Kelkar & Company Ltd — Quarterly revenue & net profit

Revenue Net Profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹650 Cr, net profit ₹2 Cr.

Full financials →

📊 Revenue & Sales Performance

  • The company expects a revenue CAGR of approximately 15% over the next 3 to 4 years.
  • EBITDA margins are targeted to improve from the current 11-12% level to around 18% within 2 to 3 years.
  • Growth momentum is strong with sustained traction in new initiatives and global accounts.
  • The second half of FY26 is expected to see better growth compared to the first half, supported by improved market conditions and ramp-up of new capacity.
  • The brownfield expansion in the Netherlands and the new factory starting operations in early FY27 will enhance capacity and cost efficiency.
  • New creative development centers in the U.S., Europe, and India aim to accelerate product development and market penetration, contributing to volume growth.
  • Overall, strong business momentum and operating leverage are expected to drive faster EBITDA growth alongside the top line.

📈 Profitability & Margins

  • **Revenue Growth:** Company targets a CAGR of around 15% over the next 3-4 years.
  • **EBITDA Margins:** Currently around 11-12%, expected to improve to 14-15% in H2 FY26 and reach 18%+ EBITDA margin in 2-3 years; long-term target is 18-20% EBITDA margin by FY27.
  • **Profitability:** Investments in new initiatives (~Rs. 32 crore in H1 FY26) will mute EBITDA short-term but are expected to yield substantial margin improvements within 2-3 years.
  • **EPS:** Expected to improve in line with margin expansion and revenue growth; no explicit EPS figures given, but steady operating leverage and lower costs from factory consolidation will aid profit growth.
  • **Other Factors:** Gross margin anticipated to improve by about 1-1.5% due to raw material cost stabilization; factory capacity expansions and creative development centers to support sustained future profit growth.

🏗️ Capital Expenditure Plans

  • Rs. 60 crore discretionary investment related to a new factory expected to start by March; requires 2-3 years to yield returns.
  • Current investment run rate in new initiatives is about Rs. 17 crore per quarter, totaling Rs. 32 crore in the recent half-year.
  • No major new financial investments or capex planned for the next 1 to 2 years.
  • New factory construction on schedule; operations expected to begin in Q1 calendar year (Q4 FY26).
  • Investment tied to readiness for global accounts engagement in U.S., Europe, and other geographies; focus on calibrated growth.
  • The company is cautious following a recent fire incident and emphasizes controlling investments to ensure quicker returns.
  • Management open to derisking strategies, including exploring partnerships or contract manufacturing, especially in Europe and U.S.

💰 Fundraising & Capital Structure

  • The company does not plan any major new financial investments for at least the next 1 to 2 years.
  • Current investments, such as the new factory expected to start by March, involve discretionary spending of around Rs. 60 crore.
  • Management is focused on controlling costs and ensuring returns on existing investments rather than initiating new capex or opex.
  • Debt levels are stable, with some expected reduction as insurance payments come through.
  • No mention of any planned new equity fundraising was made.
  • The company continues to monitor risk carefully, but no immediate plans for raising funds through debt or equity were indicated in the transcript.

📋 Order Book & Pipeline

  • The company has assured business exceeding $10 million for the current year from global contracts.
  • They continue to submit and make progress in newer projects but do not have specific announcements on larger orders yet.
  • Flavour tender approvals have been obtained; initial trial orders have been placed, but full-scale business development is expected to be multi-year.
  • The U.S. and Europe markets are key targets, with new initiatives including creative development centers in the U.S. and ongoing global account engagements.
  • Management is monitoring new initiatives carefully due to investment and external risks but is confident about growth opportunities ahead.

Key Metrics

Frequently Asked Questions

What were S H Kelkar & Company Ltd Q2 FY26 results?

The company expects a revenue CAGR of approximately 15% over the next 3 to 4 years. Revenue Growth:** Company targets a CAGR of around 15% over the next 3-4 years.

What is S H Kelkar & Company Ltd share price analysis?

S H Kelkar & Company Ltd currently shows a neutral. The stock trades at a P/E of 50.0 with a market cap of ₹2,363 Cr. Investors should review the full earnings analysis for detailed insights.

Is S H Kelkar & Company Ltd planning capital expenditure?

Rs.

Keep S H Kelkar & Company Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

Others in Chemicals & Petrochemicals this season

  • Alkyl Amines (Q2 FY26)

    120 crores. Key concall takeaways from Alkyl Amines Chemicals Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.

  • Sudarshan Chem. (Q2 FY26)

    The company completed a significant capex investment of roughly INR 700 crores about 3-4 years ago. Key concall takeaways from Sudarshan Chemical Industries…

  • G N F C (Q2 FY26)

    Capex pipeline worth INR 2,800 crores includes expansions in AN melt, weak nitric acid, power and steam plant conversion, and ammonia loop expansion. Key…

  • Pidilite Inds. (Q2 FY26)

    Growth in the Consumer and Bazaar segment sustained at 10%, driven by core and pioneering categories like Roff and electronic adhesives (Page 7). Key concall…